Search Results - "SACCHINI, V"

Refine Results
  1. 1

    Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance by Manning, A. T., Wood, C., Eaton, A., Stempel, M., Capko, D., Pusic, A., Morrow, M., Sacchini, V.

    Published in British journal of surgery (01-10-2015)
    “…Background Nipple‐sparing mastectomy (NSM) is associated with improved cosmesis and is being performed increasingly. Its role in BRCA mutation carriers has not…”
    Get full text
    Journal Article
  2. 2

    Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ by Magnoni, F., Massari, G., Santomauro, G., Bagnardi, V., Pagan, E., Peruzzotti, G., Galimberti, V., Veronesi, P., Sacchini, V. S.

    Published in British journal of surgery (01-03-2019)
    “…Background Microinvasive breast cancer is an uncommon pathological entity. Owing to the rarity of this condition, its surgical axillary management and overall…”
    Get full text
    Journal Article
  3. 3

    Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging? by Magnoni, Francesca, Colleoni, M., Mattar, D., Corso, G., Bagnardi, V., Frassoni, S., Santomauro, G., Jereczek-Fossa, B. A., Veronesi, P., Galimberti, V., Sacchini, V., Intra, M.

    Published in Annals of surgical oncology (01-10-2020)
    “…Background Contralateral axillary lymph node metastasis (CAM) is an infrequent clinical condition currently considered an M1, stage IV, disease. Due to the…”
    Get full text
    Journal Article
  4. 4

    Use of bilateral prophylactic nipple-sparing mastectomy in patients with high risk of breast cancer by Valero, M G, Moo, T-A, Muhsen, S, Zabor, E C, Stempel, M, Pusic, A, Gemignani, M L, Morrow, M, Sacchini, V

    Published in British journal of surgery (01-09-2020)
    “…Abstract Background Nipple-sparing mastectomy (NSM) is being performed increasingly for risk reduction in high-risk groups. There are limited data regarding…”
    Get full text
    Journal Article
  5. 5

    1st International consensus guidelines for advanced breast cancer (ABC 1) by Cardoso, F, Costa, A, Norton, L, Cameron, D, Cufer, T, Fallowfield, L, Francis, P, Gligorov, J, Kyriakides, S, Lin, N, Pagani, O, Senkus, E, Thomssen, C, Aapro, M, Bergh, J, Di Leo, A, El Saghir, N, Ganz, P.A, Gelmon, K, Goldhirsch, A, Harbeck, N, Houssami, N, Hudis, C, Kaufman, B, Leadbeater, M, Mayer, M, Rodger, A, Rugo, H, Sacchini, V, Sledge, G, van’t Veer, L, Viale, G, Krop, I, Winer, E

    Published in Breast (Edinburgh) (01-06-2012)
    “…Abstract The 1st international Consensus Conference for Advanced Breast Cancer (ABC 1) took place on November 2011, in Lisbon. Consensus guidelines for the…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women by Veronesi, U, Maisonneuve, P, Costa, A, Sacchini, V, Maltoni, C, Robertson, C, Rotmensz, N, Boyle, P

    Published in The Lancet (British edition) (11-07-1998)
    “…Tamoxifen is a candidate chemopreventive agent in breast cancer, although the drug may be associated with the development of endometrial cancer. Therefore we…”
    Get full text
    Journal Article
  7. 7

    Evaluating the role of intra-operative radiation therapy in the modern management of breast cancer by Barry, M, Sacchini, V

    Published in Surgical oncology (01-12-2012)
    “…Abstract Over the last 10 years, intra-operative radiotherapy (IORT) has been used extensively in the clinical trial setting but has yet to make a significant…”
    Get full text
    Journal Article
  8. 8

    Tamoxifen for breast cancer among hysterectomised women by Veronesi, U, Maisonneuve, P, Sacchini, V, Rotmensz, N, Boyle, P

    Published in The Lancet (British edition) (30-03-2002)
    “…Tamoxifen is a candidate drug for prevention of breast cancer, although findings from trials have not been consistent. In our extended follow-up (median 81·2…”
    Get full text
    Journal Article
  9. 9

    Study of quadrant high-dose intraoperative radiation therapy for early-stage breast cancer by Sacchini, V., Beal, K., Goldberg, J., Montgomery, L., Port, E., McCormick, B.

    Published in British journal of surgery (01-09-2008)
    “…Background: Partial breast irradiation has been tested in limited pilot studies and shown to provide acceptable cosmesis, minimal toxicity and adequate local…”
    Get full text
    Journal Article
  10. 10

    Sentinel lymph node biopsy and Axillary dissection in breast cancer : Results in a large series by VERONESI, U, PAGANELLI, G, DE CICCO, C, INTRA, M, TOSI, G, SCARPA, D, VIALE, G, GALIMBERTI, V, LUINI, A, ZURRIDA, S, ROBERTSON, C, SACCHINI, V, VERONESI, P, ORVIETO, E

    “…Axillary lymph node dissection is an established component of the surgical treatment of breast cancer, and is an important procedure in cancer staging;…”
    Get full text
    Journal Article
  11. 11

    Local approaches to hereditary breast cancer by Cooper, B T, Murphy, J O, Sacchini, V, Formenti, S C

    Published in Annals of oncology (01-11-2013)
    “…The diagnostic and local treatment modalities of hereditary breast cancer (HBC) are evolving based on emerging evidence from new imaging, radiotherapy and…”
    Get full text
    Journal Article
  12. 12

    The evolving role of axillary lymph node dissection in the modern era of breast cancer management by Barry, J.M, Weber, W.P, Sacchini, V

    Published in Surgical oncology (01-06-2012)
    “…Abstract The standard of practice in breast cancer surgery is that all patients with a positive sentinel node mandate an axillary lymph node dissection (ALND)…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Comparison of radioguided excision with wire localization of occult breast lesions by Luini, A., Zurrida, S., Paganelli, G., Galimberti, V., Sacchini, V., Monti, S., Veronesi, P., Viale, G., Veronesi, U.

    Published in British journal of surgery (01-04-1999)
    “…Background: Clinically occult breast lesions are found with increasing frequency as a result of the widespread use of mammographic screening. Methods: This…”
    Get full text
    Journal Article
  15. 15

    Prediction of response to primary chemotherapy for operable breast cancer by Colleoni, M, Orvieto, E, Nolé, F, Orlando, L, Minchella, I, Viale, G, Peruzzotti, G, Robertson, C, Noberasco, C, Galimberti, V, Sacchini, V, Veronesi, P, Zurrida, S, Orecchia, R, Goldhirsch, A

    Published in European journal of cancer (1990) (01-04-1999)
    “…The use of primary systemic cytotoxics leads to a high remission rate in patients with breast cancer. Response was identified as an important variable…”
    Get full text
    Journal Article
  16. 16

    A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer by Bevilacqua, J.L.B., Gucciardo, G., Cody, H.S., MacDonald, K.A., Sacchini, V., Borgen, P.I., Van Zee, K.J.

    Published in European Journal of Surgical Oncology (01-09-2002)
    “…Internal mammary lymph-node (IMN) metastases in breast carcinomas have a major influence on survival, comparable with the influence of axillary lymph-node…”
    Get full text
    Book Review Journal Article
  17. 17

    Nipple-sparing and skin-sparing mastectomy: Review of aims, oncological safety and contraindications by Galimberti, Viviana, Vicini, Elisa, Corso, Giovanni, Morigi, Consuelo, Fontana, Sabrina, Sacchini, Virgilio, Veronesi, Paolo

    Published in Breast (Edinburgh) (01-08-2017)
    “…Skin-sparing (SSM) and nipple-sparing (NSM) mastectomies are relatively new conservative surgical approaches to breast cancer. In SSM most of the breast skin…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial by DECENSI, A, ROBERTSON, C, ROTMENSZ, N, SEVERI, G, MAISONNEUVE, P, SACCHINI, V, BOYLE, P, COSTA, A, VERONESI, U

    Published in British journal of cancer (01-09-1998)
    “…The combination of tamoxifen and transdermal hormone replacement therapy (HRT) may potentially reduce risks and side-effects of either agent, but an adverse…”
    Get full text
    Journal Article